
Financial Management Solutions
Dawn Health Secures 11.5 Million To Scale Platform & Product Suite For Next-Gen Pharma Digital Health Solutions
By PR Newswire

COPENHAGEN, Denmark, May 5, 2025 /PRNewswire/ -- Dawn Health, a global leader in digital health, has secured a funding round of €11.5 million from its existing investors: Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork. The investment is aimed at supporting the company's strategy to deliver its platform and product suite to global pharma companies through a SaaS model, while continuing to invest in further offerings within the Dawn Product Suite.
Since 2021, Dawn Health has been dedicated to developing a best-in-class platform designed specifically to accommodate the needs and use cases of the pharmaceutical industry. The Dawn Platform and Product Suite have already been widely adopted by five global industry leaders, including Merck and Novartis. The Dawn Platform is currently used in areas such as oncology, multiple sclerosis, and rare pediatric conditions like growth disorders. It helps patients manage their treatment, report symptoms, and stay in close contact with their healthcare team.
The Dawn Platform and Product Suite empower pharma companies, patients, and healthcare professionals to improve outcomes and patient care by leveraging advanced capabilities in AI, data, evidence generation, clinical integrations, personalization, and connected health. By improving both data collection and analytics, these capabilities ultimately benefit patients and pharma companies alike, positioning the Dawn Platform as the foundation for therapy companions, disease management programs, and real-world evidence (RWE) solutions that enable the next generation of digital health.
"Our ambition is to be the global leader in digital health, powering pharma's next-generation products – and ultimately improving the lives of patients worldwide," said Alexander Mandix Hansen, CEO of Dawn Health. "This funding allows us to bring our proven platform to more markets and deepen our impact."
This next phase reinforces Dawn Health's position as a trusted partner to pharma companies, delivering valuable, scalable, regulatory-grade digital health products that evolve with the needs of modern medicine.
"Since the major investment in December 2021, Dawn Health has grown its revenue significantly and expanded its footprint in global pharma. With more than 100 employees, unique solutions, and a strong regulatory infrastructure, we are prepared to further accelerate our growth," says Chairman Lars Marcher.
About Dawn Health
Dawn Health is a global leader in digital health, specializing in the development of Software as a Medical Device (SaMD), Digital Therapeutics (DTx), and connected health solutions. Accelerating the launch of digital solutions to market, the Dawn Health product suite drives innovation to change the lives of people with chronic conditions. Through close partnerships with the life sciences industry, Dawn Health creates digital health products that transform patient care through an empathetic and human-centric approach.
Logo - https://mma.prnewswire.com/media/2678720/Dawn_Health_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/dawn-health-secures-11-5-million-to-scale-platform--product-suite-for-next-gen-pharma-digital-health-solutions-302445144.html
SOURCE Dawn Health
Frequently Asked Questions
What is Dawn Health?
Dawn Health is a global leader in digital health, specializing in Software as a Medical Device (SaMD), Digital Therapeutics (DTx), and connected health solutions. They develop platforms to improve patient care and outcomes.
How does Dawn Health's platform work?
The Dawn Platform helps patients manage treatment, report symptoms, and connect with healthcare teams. It leverages AI, data analytics, and clinical integrations for personalized care.
Who are Dawn Health's investors?
Dawn Health's investors include Chr. Augustinus Fabrikker, the Export and Investment Fund of Denmark (EIFO), and Trifork.
First published on Mon, May 5, 2025
Enjoyed what you read? Great news – there’s a lot more to explore!
Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!
Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.
Head to the TechDogs homepage to Know Your World of technology today!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending PR Newswire
Alithya Appoints Pierre Blanchette As Chief Financial Officer
By PR Newswire
Amendola Earns Three Prestigious Healthcare And Health Tech-Focused PR Awards
By PR Newswire
Bingx Introduces Copy Trading 2.0: Greater Control, Transparency, And Flexibility
By PR Newswire
Chargeflow Launches Industry's First Fully Automated Chargeback Solution In The Woocommerce Marketplace
By PR Newswire
Chatmeter Launches AI Tools For Healthcare Providers, Integrates With Webmd And Vitals.Com To Elevate Patient Experience And Ensure Compliance
By PR Newswire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion